Raadi | Blue Cross MN

Soo bandhiga 2281 - 2290 ee natiijooyinka 3167

Bixiye

P82-20 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020

Bixiye

P79-20 Change in Medical Necessity Criteria to InterQual® for Substance Use Disorder Admissions

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020

Bixiye

P83-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020

Bixiye

P77-20 2021 Medicare Product Acupuncture Benefit Changes

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020

Bixiye

QP106-20 CPT Code 99072 Will Not Be Separately Reimbursed

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2020

Bixiye

QP105-20 Update: EquiClaim to Perform Focused and Limited Hospital Bill Validation (HBV) Services

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2020

Bixiye

QP103-20 Commercial Pharmacy Benefit Exclusion for Emtricitabine-Tenofovir Disoproxil Fumarate Tablet 200-300 mg

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2020

Bixiye

QP104-20 Update: Cotiviti to Perform Focused and Limited Hospital Bill Validation (HBV) Services

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2020

Bixiye

QP100-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor IX PA with QL

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2020

Bixiye

QP95-20 Commercial Pharmacy Benefit Exclusion for Jelmyto®

Wax badan akhri

Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2020